Ronald N. Warner

Plus aucun poste en cours

70 ans

Health Technology

Profil

Ronald N.
Warner has been Chief Scientific Officer of Alpharma, Inc. since June 19, 2008 and Executive Vice President of Compliance and Intellectual Property since January 2005.
Dr. Warner was President of Pharmaceuticals for Alpharma from January 2005 to June 2008.
Previously, he was an Executive Vice President of Human Scientific Affairs, Compliance and Intellectual Property for Alpharma from January 2004 to January 2005, Executive Vice President of Human Scientific Affairs and Intellectual Property from February 2003 to January 2004 and Vice President of Global Scientific Affairs and Human Pharmaceuticals from December 2002 to February 2003.
Dr. Warner was Vice President and General Manager of ESI Lederle from 2001 to 2002 and Vice President of Research and Development from 1995 to 2001.

Anciens postes connus de Ronald N. Warner

Sociétés	Poste	Fin
ESI Lederle ESI Lederle Pharmaceuticals: MajorHealth Technology Part of Baxter International, Inc., ESI Lederle is a company that manufactures and distributes injectable drugs. The company is based in Cherry Hill, NJ. ESI Lederle was acquired by Baxter Healthcare Corp. from Wyeth LLC on December 20, 2002 for $305 million.	Corporate Officer/Principal	01/01/2002
Zoetis Products LLC Zoetis Products LLC Pharmaceuticals: MajorHealth Technology Zoetis Products LLC engaged in the manufacturing of pharmaceutical products. The company was founded in 1975 and was headquartered in Florham Park, NJ.	Directeur Technique/Scientifique/R&D	-

Voir l'expérience en détail de Ronald N. Warner

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées